chr17-31095346-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_001042492.3(NF1):​c.37G>T​(p.Val13Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V13A) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NF1
NM_001042492.3 missense

Scores

3
1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.84

Publications

1 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
MIR4733HG (HGNC:55332): (MIR4733 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 41 uncertain in NM_001042492.3
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16394371).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NF1NM_001042492.3 linkc.37G>T p.Val13Leu missense_variant Exon 1 of 58 ENST00000358273.9 NP_001035957.1 P21359-1
NF1NM_000267.4 linkc.37G>T p.Val13Leu missense_variant Exon 1 of 57 NP_000258.1 P21359-2
NF1NM_001128147.3 linkc.37G>T p.Val13Leu missense_variant Exon 1 of 15 NP_001121619.1 P21359-5
MIR4733HGNR_186435.1 linkn.145C>A non_coding_transcript_exon_variant Exon 1 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NF1ENST00000358273.9 linkc.37G>T p.Val13Leu missense_variant Exon 1 of 58 1 NM_001042492.3 ENSP00000351015.4 P21359-1

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1387732
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
684784
African (AFR)
AF:
0.00
AC:
0
AN:
31584
American (AMR)
AF:
0.00
AC:
0
AN:
35662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35868
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39912
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4152
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078548
Other (OTH)
AF:
0.00
AC:
0
AN:
57746
GnomAD4 genome
Cov.:
30

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Uncertain:1
Feb 22, 2019
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.V13L variant (also known as c.37G>T), located in coding exon 1 of the NF1 gene, results from a G to T substitution at nucleotide position 37. The valine at codon 13 is replaced by leucine, an amino acid with highly similar properties. This nucleotide position is highly conserved in available vertebrate species. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Benign
-0.056
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.39
.;T;.;.
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.64
D
LIST_S2
Uncertain
0.93
D;D;D;D
M_CAP
Pathogenic
0.44
D
MetaRNN
Benign
0.16
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.73
N;N;N;N
PhyloP100
3.8
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
0.26
.;N;N;N
REVEL
Benign
0.12
Sift
Benign
1.0
.;T;T;T
Sift4G
Benign
1.0
.;T;T;T
Polyphen
0.71
P;B;B;.
Vest4
0.41, 0.41
MutPred
0.21
Loss of MoRF binding (P = 0.1173);Loss of MoRF binding (P = 0.1173);Loss of MoRF binding (P = 0.1173);Loss of MoRF binding (P = 0.1173);
MVP
0.45
MPC
0.68
ClinPred
0.52
D
GERP RS
2.7
PromoterAI
0.085
Neutral
Varity_R
0.12
gMVP
0.77
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060500261; hg19: chr17-29422364; API